Filing Flows › Procept BioRobotics (PRCT) › Q1 2025
Procept BioRobotics (PRCT) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 2, 2025
Procept BioRobotics (PRCT) reported revenue of $69.2M for the first quarter 2025 (Q1 2025), +55% from a year earlier and +1% from the quarter before. Operating margin was -39.7%, net loss $24.7M (35.8% of revenue).
Procept BioRobotics, Q1 2025: revenue $69.2M (+55% year over year), operating margin -39.7%, net loss $24.7M, operating cash flow −$17.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $69.2M | +1% | +55% |
| Operating profit | −$27.4M | — | — |
| Net earnings | −$24.7M | — | — |
| Operating cash flow | −$17.0M | — | — |
What changed
Revenue was $69.2M in Q1 2025, up 55% year over year and up 1% from the previous quarter.
Gross margin was 63.9%, up 7.6 points from a year earlier. Operating costs exceeded revenue by $27.4M, an operating margin of -39.7%. Operating expenses grew 36% against revenue growth of 55%. The fastest-growing cost line was SG&A (+39%). The quarter ended with a net loss of $24.7M, wider than the previous quarter's $18.9M loss.
Operating cash flow was −$17.0M. Non-cash charges added back $1.5M of depreciation and amortization and $10.1M of share-based compensation. Working capital and other items used $3.8M. Capital expenditures of $1.8M exceeded it, leaving free cash flow of −$18.8M.
Questions
What was Procept BioRobotics' revenue in the first quarter 2025?
Procept BioRobotics (PRCT) reported revenue of $69.2M for the first quarter 2025 (Q1 2025), +55% from a year earlier and +1% from the quarter before.
Was Procept BioRobotics profitable in the first quarter 2025?
Operating loss was $27.4M (-39.7% of revenue) and net loss $24.7M.